| 000 | 01565 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250514063357.0 | ||
| 264 | 0 | _c20031223 | |
| 008 | 200312s 0 0 eng d | ||
| 022 | _a0042-9007 | ||
| 024 | 7 |
_a10.1046/j.1423-0410.2003.00279.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTrejo, S R | |
| 245 | 0 | 0 |
_aEvaluation of virus and prion reduction in a new intravenous immunoglobulin manufacturing process. _h[electronic resource] |
| 260 |
_bVox sanguinis _cApr 2003 |
||
| 300 |
_a176-87 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Validation Study | ||
| 650 | 0 | 4 |
_aCaprylates _xpharmacology |
| 650 | 0 | 4 | _aChemical Precipitation |
| 650 | 0 | 4 | _aChromatography |
| 650 | 0 | 4 |
_aDisinfection _xmethods |
| 650 | 0 | 4 |
_aDrug Contamination _xprevention & control |
| 650 | 0 | 4 |
_aDrug Industry _xmethods |
| 650 | 0 | 4 | _aFiltration |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulins, Intravenous _xstandards |
| 650 | 0 | 4 |
_aManufactured Materials _xstandards |
| 650 | 0 | 4 |
_aPrion Diseases _xprevention & control |
| 650 | 0 | 4 |
_aPrions _xisolation & purification |
| 650 | 0 | 4 |
_aVirus Diseases _xprevention & control |
| 650 | 0 | 4 |
_aViruses _xisolation & purification |
| 700 | 1 | _aHotta, J A | |
| 700 | 1 | _aLebing, W | |
| 700 | 1 | _aStenland, C | |
| 700 | 1 | _aStorms, R E | |
| 700 | 1 | _aLee, D C | |
| 700 | 1 | _aLi, H | |
| 700 | 1 | _aPetteway, S | |
| 700 | 1 | _aRemington, K M | |
| 773 | 0 |
_tVox sanguinis _gvol. 84 _gno. 3 _gp. 176-87 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1423-0410.2003.00279.x _zAvailable from publisher's website |
| 999 |
_c12463454 _d12463454 |
||